Skip to main content

Table 1 Verification of microarray analysis by Real Time – Polymerase Chain Reaction: In order to evaluate the SN-38-mediated activation of pro-apoptotic pathways, we confirmed the microarray results with real-time PCR using total RNA from 18 h post SN-38 exposure of the SW-620 cells and control. Primer express software from ABI has been used to design the primers for real-time PCR (amplicon sizes were about 70 bp). Gene symbols and Probe Set ID numbers are as found at the NCBI website http://www.ncbi.nlm.nih.gov and NetAffx™ Analysis Center http://www.affymetrix.com/analysis/index.affx. Data are averages from two separate experiments, each in duplicate. Data are reported as the fold change of gene expression level SN-38 treated cells versus no treatment control. FC = fold change.

From: SW-620 cells treated with topoisomerase I inhibitor SN-38: gene expression profiling

Gene Symbol

Affymetrix Probe Set ID

Primer for RT-PCR

RT-PCR avg. FC

Microarray avg. FC

β-actin

NM_001101

F: CGATCCACACGGAGTACTTG

R: GGATGCAGAAGGAGATCACTG

NC

NC

RGC32

218723_s_at

F: GAAGCCTTCATTGCTGATCTTG

R: GTCCTCGGAACTTTCTGAAGCT

6.2

6.5

ITGB7

205718_at

F: CGGCTCTCGGTGGAAATCTAT

R: GGTCGTGATGGCACTTTTGTAG

3.1

7.8

PDCD4

202731_at

F: GTGCTGGAGCGGTTTGTAGAA

R: CCTTCGCTTACAAAACGCTTTC

1.8

2.5

ABAT

209459_s_at

F: CTGTTGGTTCAACGTGGTTTCC

R: GCATTTCGGTATCATCTGCCTG

3.4

6.7

DKK3

214247_s_at

F: ACCCCTGTCCAGATTATTGGC

R: TTGTTTCCATCTCCTCCCCTC

4.4

6

LYZ

213975_s_at

F: CGCTACTGGTGTAATGATGGCA

R: CAAGCTACAGCATCAGCGATGT

4.6

11

CCL20

205476_at

F: GTCTGTGTGCGCAAATCCAA

R: CCATTCCAGAAAAGCCACAGTT

3.6

10.6

UBD

205890_s_at

F: TTGCAATGGAAAGAGACTGGAA

R: AGGAAGAGTAAGTTGCCCTTTCTG

28.2

17.9

FGF3

214571_at

F: AATCAGGGTCCAGTGGGAACT

R: CAAATGCCCTGCATTGCA

-12.6

-5.1

FAF1

218080_x_at

F: CGGTGGAACCAGCCATTC

R: TTGGCGAGGAGCCCTTCT

-4.8

-5.1

HIST1H2BK

208527_x_at

F:TACGTGTACAAGGTGCTGAAACAG

R: CATGATCCCCATGGCTTTAGA

-8.6

-6.1

Cyclin E1

213523_at

F: CACCAGCCACCTCCAGACA

R: GTGGGAGTCCCTTAGGTCAACTAG

3.1

2.2

Cyclin E2

205034_at

F:GAAGTAGCCGTTTACAAGCTAAGCA

R: GCCTGGATTATCTGGGCTTCT

3.2

4.1

TNFRSF6

216252_x_at

F: AATCATCAAGGAATGCACACTCA

R: AAGCCACCCCAAGTTAGATCTG

4.2

4.5